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Abstract After failure of curative radiotherapy (RT),
surgery is the main therapeutic option to control recurrent
laryngeal cancer. Recurrences after RT for T1–T2 tumours
of the glottic larynx are often diagnosed at a more severe
stage than the original disease and, thus, usually treated by
radical approaches. Our aim is to investigate the feasibility
of more conservative strategies for proper treatment of
post-RT recurred glottic cancer. We collected and
reviewed our files from 1990 to 2006, selecting 75 patients
which matched the following inclusion criteria: (1) patient
was originally diagnosed with early stage squamous cell
carcinoma of the glottic larynx (stage I–II according to
2010 TNM), (2) patient was treated by RT with curative
intent, (3) patient presented a recurrence of disease after
RT which was surgically treated at our Institution. T stage
at first diagnosis was T1a in 41 cases (55 %), T1b in 12
(16 %) and T2 in 22 (29 %). At clinical examination of
RT-recurred lesions, we documented advanced lesions
(rT3–rT4) in 29 out of 75 patients (39 %). Overall, an
upstage was reported for 56 % RT-recurred cancers, while
37.3 % remained at the same stage than the original tumour
and 6.7 % were downstaged. Twelve patients (16 %)
underwent salvage partial laryngectomy (SPL), while 63
(84 %) received a salvage total laryngectomy (STL).
Multivariate analysis showed that rTNM according to the
AJCC-UICC of 2010 was the only prognostic factor for
both disease-free survival (p = 0.042) and overall survival
(p = 0.004). Considering the prognostic impact of rT and
rN we documented a statistical significance only in terms
of overall survival for both factors (p = 0.004 and
p = 0.04, respectively). Although STL remains the most
frequent treatment choice for failures after RT in laryngeal
carcinomas, SPL represents a valid option for selected
patients with limited recurrence and can deliver good on-
cologic and functional results if performed according to
careful indications.
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Introduction
Early glottic cancer is a malignant neoplasm which
develops in the glottic laryngeal region and it is charac-
terized by normal cord mobility [1]. According to the new
TNM classification for head and neck cancer updated in
2010 by the American Joint Committee for Cancer (AJCC)
and the Union Internationale Contre le Cancer (UICC), this
category includes neoplasms classified as T1aN0M0,
T1bN0M0 (stage I), and T2N0M0 (stage II) [2–4]. As
promoted by guidelines and medical evidence [5, 6], early
glottic cancer can be treated either with curative radio-
therapy (RT) or with surgery, guaranteeing a comparable
overall survival. RT is often preferred as primary treatment
because it grants a better anatomical preservation and, thus,
functional integrity of the larynx [7–9]. However, the risk
of local recurrence after primary RT is estimated in liter-
ature to be as high as 5–10 % for T1 lesions and 20–40 %
for T2 lesions [10]. In case of recurrence, surgery is the
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only salvage treatment option and, for the past decades, this
directly translated to salvage total laryngectomy (STL)
[10].
Until mid-nineties total laryngectomy represented the
most performed type of salvage surgery. This was mainly
due to a higher rate of complications associated with partial
laryngectomy after RT and to the opinion that these pro-
cedures were unable to achieve good oncological results
due to increased aggressiveness of RT-recurred cancer.
Since second mid-nineties, several authors [5, 10, 11]
have proposed in selected cases salvage partial laryngecto-
mies (SPLs), that include supracricoid partial laryngectomy
(SCPL, such as cricohyoidopexy, cricohyoidoepiglottopexy,
tracheohyoidopexy, tracheohyoidoepiglottopexy) and endo-
scopic CO2 laser cordectomy, as an alternative to STL in the
treatment of laryngeal recurrence after RT, allowing to pre-
serve laryngeal functions [10]. Even if the common indica-
tions for salvage laryngeal surgery after radiotherapy
treatment are the same of those recommended for primary
laryngeal cancer treatment, the correct staging of the recur-
rent tumour is the real challenge to select the most suitable
surgical indication.
The aim of this study is to review the experience of our
Institution from the second mid-nineties and to report
functional and oncological outcomes of salvage surgery for
early glottic cancer after RT failure.
Methods
Between 1990 and 2006 we identified 75 patients, previ-
ously treated by radiotherapy for early glottic cancer,
which underwent, under general anaesthesia, diagnostic
direct laryngoscopy to confirm the presence of a recurred
laryngeal squamous cell carcinoma, at the ENT Clinic of
the University of Florence. The diagnosis was completed
by CT and chest radiography, to better evaluate laryngeal
recurrence and to exclude lung metastases. TNM staging
was corrected using the 2010 edition based on the clinical
records available [12]. In Table 1, an overview of the
clinical series is shown.
All patients except one were male and mean age was
63.2 years (range 40–80, median 65.6) (p = 0.562).
Prior to RT, 41 patients (55 %) presented with T1a
staged tumours, 12 (16 %) with T1b and 22 (29 %) with T2
lesions, (p = 0.292).
Primary treatment consisted of a median total radiation
dose of 6,600 cGy (range 5,600–7,200 cGy) in 32 fractions
(range 27–49 fractions) in 47 days (range 29–75 days) on
the primary laryngeal tumours. Follow-up included indirect
laryngoscopy at regular intervals, monthly for the first year
and every second month from the second year, supple-
mented by regular 6 months CT scan for the first 3 years.
The diagnosis of local recurrence and restaging were
performed using the same criteria used to stage the original
laryngeal tumours, which consisted in clinical examination,
direct laryngoscopy under general anaesthesia with multi-
ple biopsies and CT of neck and thorax. According to the
above-reported diagnostic procedures, patients with histo-
logically documented laryngeal recurrence after RT were
surgically treated at our Institution either by STL or SPL.
Table 2 shows the type of salvage surgery performed in our
series.
Disease-free survival (DFS) and overall survival (OS)
were calculated using the Kaplan-Meier curves. Predictive
factors of survival were identified by univariate and mul-
tivariate analysis considering the following variables: age,
T and N stage, rT and rN stage, field of irradiation (glottic
region, larynx or concurrent larynx and neck), extension of
lesion at first diagnosis and at restaging (glottic, supra-
glottic, hypoglottic, transglottic), disease-free interval
between RT and local recurrence. Results were statistically
evaluated using the Fisher exact test. Statistical analysis
Table 1 Clinical data of 75 patients
Overall
(n = 75)
SPL
(n = 12)
STL
(n = 63)
p Value
Age group (years)
\60 18 (24 %) 3 (25 %) 15 (24 %) 0.562
C60 57 (76 %) 9 (75 %) 48 (76 %)
Sex 1
Female 1 (1.3 %) 0 1 (2 %)
Male 74 (98.7 %) 12 (100 %) 62 (98 %)
Clinical T stage, initial
1a 41 (55 %) 5 (42 %) 36 (57 %) 0.292
1b 12 (16 %) 4 (33 %) 8 (13 %)
2 22 (29 %) 3 (25 %) 19 (30 %)
Clinical rT-stage, salvage
1a 17 (23 %) 6 (50 %) 11(17 %) \0.001
1b 7 (9 %) 2 (17 %) 5 (8 %)
2 22 (29 %) 2 (17 %) 20 (31 %)
3 20 (27 %) 1 (8 %) 19 (30 %)
4 9 (12 %) 1 (8 %) 8 (12 %)
Table 2 Type of salvage surgery performed
Type of salvage surgery N = 75 (%)
Endoscopic laser CO2 cordectomy tipe IV 6 (8 %)
CHP 1 (1.3 %)
CHEP 3 (4 %)
THP 1 (1.3 %)
THEP 1 (1.3 %)
Total laryngectomy 63 (84 %)
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has been performed with STATA statistical software for
Windows version 10.0 (Stata Corporation: College Station,
Texas USA). We have considered statistically significant
values with p \ 0.05.
Results
The time of recurrence after primary RT ranged from 3 to
39 months starting from the end of initial RT treatment,
with a median disease-free interval of 13.5 months. Sta-
tistical analysis did not show a significative association
between T stage at the time of first diagnosis and time of
recurrence (p = 0.900).
After confirmation of relapse, lesions were rT-staged
and the results are shown in Table 3. According to our
procedure, we classified an advanced laryngeal lesion
(rT3–rT4) in 29 out of 75 patients (39 %). Overall, we
documented an upstage in 56 % RT-recurred cancer, the
same stage of primary tumour in 37.3 % and only a 6.7 %
of downstaged lesions.
As shown in Table 2, STL was performed in 63 cases
(84 %) while SPL was attempted in only 12 (16 %)
recurred patients.
Most of the RT-recurred cases were rN0 and only 4
patients presented with clinical N? disease (5.3 %), all
staged as rcN1, which underwent modified radical neck
dissection (mRND type III), except for one patient who
underwent selective neck dissection (levels II–IV) for a
single ipsilateral node less than 2 cm in size. Of these
patients, one was previously irradiated on larynx and neck,
one on the entire larynx and two on the glottic region alone
for a small T1 lesion. We did not evidence a significant
difference (p = 0.47) between extension of previous field
of radiation and N? risk. Of rN0, only 3 (4 %) patients
underwent elective neck dissection (all selective neck
dissection levels II–IV). In rN0 cases, we did not perform
any neck adjuvant treatment, except for 6 patients (8 %)
who underwent additional radio and/or chemotherapy due
to an higher rT-stage (rT3, rT4) or a histologically docu-
mented highly aggressive recurrence (vascular and/or per-
ineural invasion).
One patient (1 %) had pulmonary metastases 16 months
after salvage surgery and was treated by cisplatinum-based
chemotherapy.
Survival
Comparing DFS and OS according to T-stage of original
laryngeal cancer and rT-stage of the well-documented
recurrence, we found that rT is the only prognostic factor
with a statistical significance in both. This is more evident
in OS (p = 0.024) (Figs. 1, 2). When we considered rTNM
stage, we confirmed a statistically significant impact of
stage only for OS (p = 0.02) (Figs. 3, 4).
According to type of salvage surgery, we compared
survival results in patients who were treated by conserva-
tive instead of radical laryngeal surgery (i.e., SPL vs STL).
In this series, patients who underwent STL had a worse
prognosis in terms of DFS and OS than patients treated
with SPL, although statistically not significant (p = 0.798
and p = 0.182, respectively).
Most of patients who underwent STL had a more
advanced disease at the time of recurrence (27 patients, the
43 %, were rT3 or rT4), while the higher re-staged cancer
in the SPL group were two patients (12.5 %) presenting
with an rT3 and rT4 (p \ 0.001, Table 1).
Seventeen patients (23 % of our series) experienced a
second recurrence after first salvage surgery, within a
median time of 10.3 months (range 4–47 months). In our
series, a high rate of unsuccessful salvage surgery was
documented in patients treated by salvage endoscopic
cordectomy type IV by Laser CO2 (50 %, 3 out of 6 cases),
while STL and SCPL showed a rate of failure of 21 % (13
out of 63 cases) and 17 % (1 out of 6 cases), respectively.
The site of failure was local in 82 % (14 of 17 cases),
regional in 12 % (2 cases) and loco-regional in 6 % (1
case). For 9 (53 %) of secondly recurred patients, no fur-
ther salvage options were possible and patients died from
their disease within 2 months; 5 (29 %) have been treated
with an extra-boost radio and/or chemotherapy and the
remaining 3 (18 %) underwent a second salvage surgery,
Fig. 1 DFS according to rT (p = 0.069)
Table 3 rT stage of recurrences
T rT1a rT1b rT2 rT3 rT4 Total
1 a 11 1 9 14 6 41
1 b 4 3 4 1 0 12
2 2 3 9 5 3 22
Total 17 7 22 20 9 75
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(67 % STL), and in only one patient (33 %) a SPL was
successfully attempted (Figs. 5, 6).
Univariate and multivariate analysis were performed to
identify prognostic factors in terms of DFS and OS. We
have considered as variables T, rT, rN, stage, rTNM stage,
field of radiation (glottic, larynx, larynx and neck), exten-
sion of lesion at first diagnosis and at restaging (glottic,
supraglottic, hypoglottic, transglottic), disease-free interval
between RT therapy and local recurrence. Tables 4, 5 and 6
show the results. According to these, univariate analysis
evidenced that rT, rN and rTNM staging were prognostic
factors for OS with a statistical significance in our series
(p = 0.004, p = 0.04 and p = 0.002, respectively). In
multivariate analysis, rT and rTNM stage were the prog-
nostic factors for both DFS (p = 0.043 and p = 0.042) and
OS (p = 0.009 and p = 0.004).
Fig. 2 OS according to rT (p = 0.024)
Fig. 3 DFS according to rTNM stage (p = 0.082)
Fig. 4 OS according to rTNM stage (p = 0.002)
Fig. 5 DFS according to salvage surgery (p = 0.798)
Fig. 6 OS according to salvage surgery (p = 0.182)
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Functional results
Functional outcomes of salvage SCPL were estimated in
our study through two parameters: mean time of removal of
nasogastric feeding and mean time of decannulation.
Median time of removal of nasogastric tube was 28.9 days.
Median value of time of decannulation was 40 days.
Among salvage SCPL group statistical analysis did not
show a significant difference in terms of functional results
between the group of patients where both arytenoids were
spared versus those who required surgical sacrifice of one
arytenoid (p = 0.78).
For patients who underwent STL mean time of removal
of nasogastric feeding was 43 days (min 9, max 230) and
mean time of removal of tracheal cannula was 56 days
(min 4, max 450). We also analyzed the influence of neck
surgery (mRND type III or selective neck dissection) on
restoration of physiological functions: mean time of
removal of nasogastric feeding and of tracheal cannula in
neck dissected patients were, respectively, 24 days (min 14
max 55) and 63 days (min 4 max 240), while for patients
who did not receive additional neck surgery were 42 days
(min 4 max 230) and 53 days (min 5, max 450), respec-
tively, (p = 0.573 and p = 0.463, respectively).
Complications
Postoperative complications after salvage surgery are
classified in early and late, as shown in Table 7.
The most common complication is pharyngocutaneous
fistula (36 patients, 32.7 %) and belonged to patients who
all underwent STL.
The management of fistula was in 29 cases out of 36
(80.5 %) conservative, with compressive dressings and
routine wounds care with wet-to-dry dressing medications;
usually, in the absence of major vessel exposure, these
strategies will result in spontaneous closure through healing
from secondary intention [13]. For two STL patients
(8.3 %) closure of the fistula required additional surgery
with a pectoralis major myocutaneuous flap while, five
more patients (21 %) underwent reparative surgery with
local flaps. On the other hand, hyperbaric therapy was
performed in 13 out of 29 conservative managed cases
(45 %) and 2 out of 7 surgically managed patients (28.5 %),
to improve wound closure, due to patients’ comorbidities,
such as diabetes or poor systemic conditions, preoperative
Table 4 Univariate analysis for DFS and OS in 75 patients surgically
salvaged after RT failure
DFS OS
T 0.085 0.172
rT 0.069 0.004
rN 0.109 0.040
RT field 0.782 0.751
Site T 0.679 0.650
Site rT 0.553 0.716
DFI 0.575 0.207
rTNM stage 0.082 0.002
Bold values indicate statistical significance at p \ 0.005
Table 5 Multivariate analysis for DFS in our series of RT-failed 75 patients
DFS Odds ratio Standard error z p [ |z| [95 % CI]
Stage 5.271068 3.8211 2.29 0.223 1.273052 21.82485
RT field 0.7521513 0.1467973 -1.46 0.144 0.5130696 1.102641
Site T 1.071633 .1258449 0.59 0.556 0.8513087 1.348979
Site rT 3.296749 2.3486373 1.32 0.564 0.5734632 1.2475479
DFI \/[ 12 months 0.9999905 0.0058987 -0.343 0.899 0.9884958 1.011619
rTNM stage 1.533217 0.3220548 2.03 0.042 1.015798 2.314195
Bold value indicates statistical significance at p \ 0.005
Table 6 Multivariate analysis for OS in our series of RT-failed 75 patients
OS Odds ratio Standard error z p [ |z| [95 % CI]
Stage 3.061133 2.141879 1.60 0.110 0.7767754 12.06338
RT field 1.221417 0.7696101 0.32 0.751 -355243 4.19955
Site T 0.7253025 0.2141722 -1.09 0.277 0.4066031 1.293802
Site rT 0.988151 0.145368 -0.08 0.935 0.7406314 1.318392
DFI \/[ 12 months 0.7334798 0.1220414 -1.86 0.628 0.5293701 1.016288
rTNM stage 2.023096 0.4592999 3.10 0.004 1.296492 3.156918
Bold value indicates statistical significance at p \ 0.005
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radio-chemo therapy. Besides, in few cases (6 cases) the
hyperbaric treatment was refused because of psychological
problems as well as a disagreement to undergo daily therapy
for 10–14 days [14].
Definitive closure of the fistula was confirmed by con-
trast-enhanced transit X-ray. Patients who experienced a
pharyngocutaneous fistula had longer mean time of dec-
annulation and of removal of nasogastric feeding if com-
pared to mean time of removal of tracheal cannula in patients
without this complication (101 days versus 28 and 76 days
versus 20 days, p \ 0.05 for both). Pharyngocutaneous fis-
tula is a negative prognostic factor in the restoration of
normal physiological functions in terms of swallowing and
respiration with a significant impact (p \ 0.0001 both). We
also tried to identify potential factors predictive of pharyn-
gocutaneous fistula, but no potentially responsible factor for
higher rate of pharyngocutaneous fistula was identified in a
logistic regression analysis.
Only one patient in our series was affected by aspiration
pneumonia. He had underwent a SCPL and was success-
fully treated with antibiotic therapy with no further epi-
sodes of aspiration.
Stoma stenosis was developed by 3 patients (4 %). All
of them successfully underwent revision surgery with sto-
mia plasty.
Two patients (2.7 %) died perioperatively because of
myocardial infarction.
Discussion
Although STL remains the most frequently performed
salvage technique after RT failure, in the recent decades
SPLs have been used allowing to preserve laryngeal
functions and to avoid permanent tracheostoma [15]. As
widely reported in literature, the most important and dif-
ficult point is to perform a correct restaging of the tumour
because strict oncological criteria must be considered
before planning conservative treatment [15].
With the diffusion of more accurate imaging and
endoscopic technologies, the possibility to better define the
limits of RT recurrence in the larynx prompted several
surgeons to successfully attempt conservative surgical
approaches. The difficulty in identifying and staging the
recurrent tumour correctly is strictly related to structural
alterations of laryngeal mucosa due to the previous RT
treatment, which could be macroscopically as well as
microscopically indistinguishable from the local recur-
rence. For this reason, clinical examination should be
implemented with biomolecular and histopathological
research to identify the RT response of the individual
tumour [16].
Survival
Disease-free survival and overall survival results vary in
relation to the salvage surgical technique employed and are
generally in agreement with similar studies published in
literature.
Endoscopic laser CO2 cordectomy type IV represents a
feasible treatment mostly for T1a and T1b lesions. Liter-
ature reveals satisfactory functional results in terms of
deglutition and quality of voice for this endoscopic pro-
cedure, while 5-year DFS was extremely variable, ranging
from 38 to 88 % [10]. Our limited number of endoscopic
treated RT-recurred lesions reported 50 % of loco-regional
control at 5 years and a 5-year overall survival rate of
67 %. Among those patients who experienced a second
recurrence, only 12 % underwent a second salvage con-
servative surgery, in line with existing literature [17]. We
observed that salvage endoscopic laser CO2 cordectomy
seems to present a high risk of second laryngeal recurrence
when compared with open partial laryngectomy approa-
ches (usually up to 70 % according to review by Agra
et al.) [10]. It is likely that the direct view of the neoplasia
together with a more extended excision of involved and
irradiated larynx in open approaches seems to guarantee a
better local control after RT relapse than these achieved by
endoscopic approaches.
Among patients treated by SCPL we recorded a 5-year
DFS rate of 83 % and an OS rate of 100 %. These data
match those present in current literature (Agra et al.) [10]
Table 7 Early and late complications according to type of salvage surgery
Early complications Overall (n = 75) SPL (n = 12) STL (n = 63) p value
Peri-operatory bleeding 2 (2.7 %) 0 2 (3.2 %) 0.576
Late complications Overall (n = 75) SPL (n = 12) STL (n = 63)
Aspiration pneumonia 1 (1.3 %) 1 (8.3 %) 0.82
Stoma stenosis 3 (4 %) 3 (4.7 %) 0.98
Pharyngocutaneous fistula 24 (32 %) 0 24 (38 %) 0.003
Bold value indicates statistical significance at p \ 0.005
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and show a better prognosis for these patients versus those
receiving STLs, which record a 5-year DFS and OS rates of
0 and 62 %, respectively.
The apparent discrepancy is obviously justified by
selection criteria for SPL (rT1–rT2 and selected rT3),
which is a procedure dedicated, for its nature, to less
aggressive or extended recurrences. These results support
the use of SPL as an oncologically sound and functionally
conservative surgical procedure for upstaged lesions
encompassing rT2 and rT3, reserving STLs for the treat-
ment of rT4 lesions or second (post salvage surgery)
recurrences as previously reported [18].
During follow-up we diagnosed a second recurrence in
23 % of patients, of which only 33 % could be surgically
treated by SPL. As evidenced in literature [19–22] and
confirmed in our study, the prognosis in these secondly
recurred patients is extremely negative and the only treat-
ment option is STL with adjuvant treatment.
When we compare DFS and OS of patients who
underwent STL and those who underwent total laryngec-
tomy as primary surgery, DFS and OS of first group are 71
and 47.5 % in contrast with 0 and 62 % for the second
group [5]. A worse prognosis is also reported for SPL as a
salvage procedure rather than primary surgery, with a DFS
of 100 % and OS of 94 % for the first-treatment group and
both 83 and 100 %, respectively, for the salvage group.
Overall, in our study, 33.3 % of our patients died as a
consequence of the post-RT recurrence, in 60 % of cases
for a second recurrence despite a STL was attempted
(84 %). As evidenced in literature [23] and confirmed in
our study, the prognosis for these patients is extremely
negative and the only option suitable is STL followed by
adjuvant treatment or curative/palliative radio and che-
motherapy. Minor causes of death were documented for
7.5 % of patients: 5.7 % experienced a second primary
extra-laryngeal cancer, 3.8 % had pulmonary metastases
and 2.7 % experienced fatal peri-operatory bleeding.
Indications for selective neck dissection in cN0 patients
are still today object of discussion. According to Ganly [5]
the decision must be based on a correct r-staging [24] to
evidence extension of recurrence in higher risk areas such
as supraglottic or hypoglottic larynx, or in case of extra-
laryngeal tissues’ involvement (which corresponds to rT3
and rT4), parameters which are predictive factors of N?
risk. Nonetheless, analyzing the data here reported we
believed that selective neck dissections in N0 RT-recurred
early glottic cancer have limited indications.
Complications and functional results
In our series we recorded an overall rate of postoperative
complications of 40 % and an incidence of postoperative
mortality of 2.7 %, while a similar report in literature
reveals a postoperative complication rate of 20 % and no
postoperative mortality [5]. SPL showed a lower rate of
postoperative complications than STL (15 vs 45 %,
p = 0.005). Comparing our results to Pellini’s work [22],
the incidence of complications for patients who underwent
SPL was 15 and 38.5 %, respectively, while perioperative
mortality was 0 and 1.3 %. The most common complica-
tion is aspiration pneumonia (17 %), a higher incidence
than in Pellini’s study (8.9 %), all treated with medical
therapy, which is a better result than Makeieff’s work
where 8.7 % of patients with aspiration pneumonia died
[24]. In our study, the incidence of early postoperative
complications was 3 %, which consisted in only one
bleeding without other complications such as neck
abscesses as showed in Pellini’s work (6.4 %). The same
two works also reported the incidence of late complica-
tions, such as granuloma of the subglottis or oedema of the
arytenoids, estimated around 17.9 %, which were not
documented in our series.
Among the 12 patients who underwent SPL restoration
of oral feeding was achieved in all patients with a mean
time of 29 days. In other studies [18, 25–28] mean time of
restoration a normal feeding was 25 days and in Pellini’s
study was in less than 1 month for 61.5 % of patients [22].
The time of removal of the feeding tube ranged in literature
from 10–96 days [28] to 12–90 days [18], in our study was
4–230 days. Only one patient (5 %) was not able to restore
normal swallowing functions and required percutaneous
endoscopic gastrostomy, similar results to Makeieff’s
(4.4 %) and Pellini’s (7.7 %) studies.
Mean time of decannulation was in our study 22.5 days
with a range of 18–35 days, which ranged in literature from
14–90 [29] to 12–365 days [19]. Our results, when com-
pared with literature, are characterized by a lower inci-
dence of pneumonia and higher time of decannulation. This
is mainly due to our philosophy (common to several
Institutions in Italy) to grant a better protection of the
airways during swallowing rehabilitation by maintaining
the tracheal cannula for a longer time. This could justify a
higher time of decannulation but a lower risk of aspiration
pneumonia, even if this usually delays restoration of nor-
mal swallowing.
STL has been associated with high rates of postoperative
complications in our study (45 %) and in many series in
literature, especially after previous radiotherapy (from 29.4
[30] to 21.9 % [5]) and chemoradiotherapy (from 41.2 to
50 %) [29]. The incidence of late complications as stoma
stenosis is estimated in literature about 9 % [5] while in our
case study was 4 % and they all required surgical re-
intervention. The most common complication is pharyn-
gocutaneous fistula, which had an incidence of 32 % in our
study, 11.9 % in Ganly’s and 30 % in Weber’s [25]. The
rate of pharyngocutaneous fistula following STL in
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irradiated patients is higher than that after total laryngec-
tomy as primary treatment (from 68 to 8.69 % [30–32]).
Because our series included only early glottic cancer,
without any patient treated with a laryngeal preservation
protocol for advanced disease, we found a higher rate of
fistulas than reported in literature. In our Institute fistula
was usually treated with a conservative approach based on
the use of a scopolamine patch and medications to have
good functional results but with long times of hospital-
ization, only 8.3 % underwent reparative surgery with a
pectoralis major myocutaneous flap.
Conclusions
To our experience, the central point of surgical treatment
recurrences after RT once the diagnosis is made is the
difficulty of restaging, which might have a dramatic impact
on planning the type of salvage surgery and prognosis, as
demonstrated by our analysis. Therefore, an accurate
evaluation of RT-recurred laryngeal carcinoma is manda-
tory to plan the surgical salvage treatment in RT-failed
early glottic cancer, being not limited to STL.
Our experience suggests that conservative approaches
are still feasible with good oncologic results, but in a
selected RT-recurred cancer and at the price of some
potential functional problems. In recurring early glottic
cancer post radiotherapy, treatment of the neck does not
usually present a hard decision for the surgeon, being the
risk of lymph node involvement very low. Analogously, we
documented for these patients a low rate of distant disease,
in contrast with the reported high risk of distant metastases
in failed patients after chemoradiation laryngeal preserva-
tion protocols for advanced laryngeal cancers.
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